相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
Shumpei Yokota et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2012)
Macrophage Activation Syndrome in Children With Systemic Lupus Erythematosus and Children With Juvenile Idiopathic Arthritis
Tellen D. Bennett et al.
ARTHRITIS AND RHEUMATISM (2012)
Systemic juvenile idiopathic arthritis
Alberto Martini
AUTOIMMUNITY REVIEWS (2012)
Leflunomide in systemic onset juvenile idiopathic arthritis
Afsana Jahan et al.
INDIAN PEDIATRICS (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
Norman T. Ilowite et al.
PEDIATRIC RHEUMATOLOGY (2012)
Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)
C. M. Hedrich et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry
A. Klein et al.
ARTHRITIS CARE & RESEARCH (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment
Yutaka Inaba et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series
Peter A. Nigrovic et al.
ARTHRITIS AND RHEUMATISM (2011)
Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis
Marieke H. Otten et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids
Normi Bruck et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
Sergio Davi et al.
JOURNAL OF RHEUMATOLOGY (2011)
Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
Jessica L. Record et al.
JOURNAL OF RHEUMATOLOGY (2011)
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
Elizabeth D. Mellins et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Etanercept treatment in juvenile idiopathic arthritis: The Polish registry
Zbigniew Zuber et al.
MEDICAL SCIENCE MONITOR (2011)
Cardiac Tamponade in a Child With Systemic-Onset Juvenile Idiopathic Arthritis: Dramatic Improvement After Interleukin-1 Blockade by Anakinra
E. Merlin et al.
PEDIATRIC CARDIOLOGY (2011)
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
Paivi M. Miettunen et al.
RHEUMATOLOGY (2011)
Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis
Vera Papsdorf et al.
RHEUMATOLOGY (2011)
Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis
Stefano Lanni et al.
RHEUMATOLOGY (2011)
Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review
Bradley J. Bloom et al.
RHEUMATOLOGY INTERNATIONAL (2011)
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman et al.
ARTHRITIS CARE & RESEARCH (2011)
Long-Term Safety and Efficacy of Abatacept in Children With Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2010)
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
Joost Frans Swart et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Effectiveness of Leflunomide in Patients with Juvenile Idiopathic Arthritis in Clinical Practice
Ivan Foeldvari et al.
JOURNAL OF RHEUMATOLOGY (2010)
Effectiveness and Toxicity of Methotrexate in Juvenile Idiopathic Arthritis: Comparison of 2 Initial Dosing Regimens
Mara L. Becker et al.
JOURNAL OF RHEUMATOLOGY (2010)
Abatacept Improves Health-Related Quality of Life, Pain, Sleep Quality, and Daily Participation in Subjects With Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
ARTHRITIS CARE & RESEARCH (2010)
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Norman Ilowite et al.
CLINICAL RHEUMATOLOGY (2009)
Anakinra for Systemic Juvenile Arthritis The Rocky Mountain Experience
Andrew Zeft et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
Ricardo A. G. Russo et al.
JOURNAL OF RHEUMATOLOGY (2009)
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
Marco Gattorno et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
Abatacept in children with juvenile idiopathic arthritis:: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto et al.
LANCET (2008)
A case of macrophage activation syndrome successfully treated with anakinra
Alison Kelly et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France
T. Lequerre et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOMA)
V. Ohlsson et al.
RHEUMATOLOGY (2008)
A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis
Salih Pay et al.
CLINICAL RHEUMATOLOGY (2006)
Macrophage activation syndrome in juvenile idiopathic arthritis
Elisabetta Cortis et al.
ACTA PAEDIATRICA (2006)
Predictors of disease course and remission in systemic juvenile idiopathic arthritis - Significance of early clinical and laboratory features
D. Singh-Grewal et al.
ARTHRITIS AND RHEUMATISM (2006)
Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis
LJ Mirkinson et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)
Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis
M Hur et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
A Ravelli et al.
JOURNAL OF PEDIATRICS (2005)
Therapeutic Efficacy of Humanized Recombinant Anti-Interleukin-6 Receptor Antibody in Children With Systemic-Onset Juvenile Idiopathic Arthritis
Shumpei Yokota et al.
ARTHRITIS AND RHEUMATISM (2005)
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
P Woo et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
S Sawhney et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study
V Gerloni et al.
RHEUMATOLOGY (2001)
分享论文
